

Fundamental dimension Equity attribute | UHSLeader $186.89▼-0.66% Cap $11.01BP/E 7.6x QuantScore65/100 | ACHCPeer $31.51▼-1.16% Cap $2.93BP/E -2.5x QuantScore44/100 | ARDTPeer $12.27▼-0.73% Cap $1.73BP/E 22.3x QuantScore56/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
87/100 |
95/100 |
84/100 |
Valuation Multiples, PEG & DCF upside | 99/100 | 33/100 | 95/100 |
Health Piotroski, Altman Z, leverage & liquidity | 56/100 | 23/100 | 39/100 |
Growth Revenue / earnings growth & margins | 51/100 | 19/100 | 15/100 |
Sentiment Analyst ratings, targets & revisions | 30/100 | 51/100 | 46/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 7.6x | -2.5x | 22.3x |
Forward P/E (next FY) | 8.3x | 20.6x | 12.8x |
EV / EBITDA (TTM) | 5.7x | -7.8x | 8.1x |
Price / Sales | 0.6x | 0.9x | 0.3x |
Price / Free Cash Flow | 13.3x | -155.1x | 5.8x |
PEG ratio | 0.27 | 0.00 | -0.32 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 8 / 9 | 4 / 9 | 5 / 9 |
Altman Z-Score | 3.14 (Safe) | 0.49 (Distress) | 2.05 (Grey) |
Total debt / equity | 0.70 | 1.30 | 1.68 |
Quick ratio | 1.0x | 1.6x | 2.0x |
Interest coverage | 13.2x | 2.2x | 9.7x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +9.7% | +5.0% | +6.0% |
Net income growth YoY | +30.4% | -531.4% | -35.4% |
Gross margin (TTM) | 90.7% | 35.6% | 30.0% |
Operating margin (FY) | 11.5% | 11.7% | 5.1% |
FCF margin (FY) | 4.9% | -13.3% | 4.1% |
5. Trailing price performancePrice change over period |
1M return | +5.6% | +13.3% | +17.1% |
3M return | +20.0% | -8.7% | +15.3% |
6M return | +7.2% | +15.1% | +26.6% |
Year to date | -14.3% | +122.1% | +39.0% |
1Y return | -11.3% | +34.7% | -19.3% |
3Y return | +50.1% | -58.0% | -23.6% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $297.20 +59.0% upside | $-117.06 -471.5% premium | $37.33 +204.2% upside |
Wall Street consensus target | $193.00 +3.3% · range $166.00–$290.00 | $34.78 +10.4% · range $30.00–$40.00 | $12.67 +3.3% · range $11.00–$14.00 |
Consensus stance | 39% Buy57% Hold5% Sell | 68% Buy28% Hold4% Sell | 67% Buy25% Hold8% Sell |